<--- Back to Details
First PageDocument Content
Agency for Healthcare Research and Quality / Evidence-based medicine / Stroke / Dabigatran / National Institutes of Health / Comparative effectiveness research / ECRI Institute / E. Andrew Balas / Medicine / Health / Chemistry
Date: 2013-08-22 14:54:53
Agency for Healthcare Research and Quality
Evidence-based medicine
Stroke
Dabigatran
National Institutes of Health
Comparative effectiveness research
ECRI Institute
E. Andrew Balas
Medicine
Health
Chemistry

Comparative Effectiveness Review Number 123 Stroke Prevention in Atrial Fibrillation

Add to Reading List

Source URL: www.effectivehealthcare.ahrq.gov

Download Document from Source Website

File Size: 2,47 MB

Share Document on Facebook

Similar Documents

Brain Injury, December 2005; 19(13): 1165–1176 CASE STUDY Assessing recovery in middle cerebral artery stroke using functional MRI

DocID: 1vlE6 - View Document

Benefits of virtual reality based cognitive rehabilitation through simulated activities of daily living: a randomized controlled trial with stroke patients

DocID: 1vli6 - View Document

UnitedWeDream-Logo-2016-v2-stroke

DocID: 1vkOH - View Document

Segmentation of Ischemic Stroke Lesion using Random Forests in Multi-modal MRI Images Qaiser Mahmood1 and A. Basit1 1 Pakistan Institute of Nuclear Science and Technology, Islamabad, Pakistan

DocID: 1viC2 - View Document

Master Thesis Proposal Embedded Development for Monitoring of Activities of Daily Living (ADL) Background: The higher prevalence of age-associated disorders such as stroke, Alzheimer’s

DocID: 1ve7I - View Document